Paid and presented by Medtronic. The growing application of digital health technologies is advancing the capabilities of insertable cardiac devices. The most recent iterations can connect to a ...

Medical technology giant Medtronic will purchase miniaturised heart device firm, Heartware, in a deal worth an estimated $1.1 billion. The deal will see Heartware’s expansive range of ...

Medical technology giant Medtronic will purchase miniaturised heart device firm, Heartware, in a deal worth an estimated $1.1 billion. The deal will see Heartware’s expansive range of ...

The U.S. Food and Drug Administration (FDA) has greenlighted Medtronic’s (NYSE:MDT) PulseSelect Pulsed Field Ablation (PFA) System targeted at a heart rhythm disorder called atrial fibrillation ...

The National Heart Centre Singapore (NHCS) and Medtronic have signed a memorandum of understanding (MOU) to enhance clinical ...

Christensen, Clayton M. "We've Got Rhythm! Medtronic Corp.'s Cardiac Pacemaker Business (TN)." Harvard Business School Teaching Note 698-056, March 1998.

Several factors have driven RBC’s decision to upgrade Medtronic. Firstly, its core business areas—such as cardiac rhythm management, spine, and surgical divisions—are expected to deliver mid ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

The HxM™ BT combines Zephyr’s patented BioHarness™ smart-fabric heart rate technology used in high-end professional markets, with speed and distance in a small, comfortable consumer device.

One of the largest medical-device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves ...

Medtronic Plc announced a voluntary recall Friday of certain insulin pumps after customers said a single drop, bump, or physical impact could shorten their battery life. The Galway, Ireland-based ...